Early Trial Shows New Treatment Hits Tough-to-Treat Glioblastomas Harder [Video]

Key Takeaways

A targeted radiation treatment could be better at treating brain tumors than standard beam radiationTargeted alpha therapy involves injecting radioactive particles that seek out cancer cellsSmall studies show that TAT increased survival rates by 16% in new glioblastoma cases and 36% in recurring tumors

THURSDAY, July 11, 2024 (HealthDay News) — Radioactive substances injected into the body could provide a better way of treating glioblastoma, the most malignant form of brain cancer, a new review says.

The cancer treatment, called targeted alpha therapy (TAT), involves injection of radioactive alpha particles attached to special molecules that seek out cancer cells in the body.

Pre-clinical experiments show that TAT increases survival rates by 16% in newly diagnosed glioblastoma cases, and by 36% in recurrent tumors, researcher reported recently in the journal Targeted Oncology.

TAT is a more powerful and precise approach to radiation therapy than external beam radiotherapy, in which a machine beams targeted …